Shanghai Kehua Bio-Engineering Co Ltd (002022) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.25 Million ≈ $4.13 Million USD) by net assets (CN¥3.70 Billion ≈ $541.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Shanghai Kehua Bio-Engineering Co Ltd fund operations to measure how many days the company can operate on defensive assets alone.

Shanghai Kehua Bio-Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Kehua Bio-Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Gladstone Investment Corporation 8.00% Notes due 2028
NASDAQ:GAINL
0.013x
Hanjia Design Croup Co Ltd Class A
SHE:300746
-0.002x
Shenyang Chemical Industry Co Ltd
SHE:000698
0.142x
Clinuvel Pharmaceuticals Ltd
AU:CUV
0.050x
Greenyard NV
BR:GREEN
0.189x
Primis Financial Corp
NASDAQ:FRST
-0.127x
Columbus McKinnon Corporation
NASDAQ:CMCO
-0.115x
Egis Technology
TWO:6462
0.002x

Annual Cash Flow Conversion Efficiency for Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Kehua Bio-Engineering Co Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Kehua Bio-Engineering Co Ltd market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.11 Billion
≈ $455.03 Million
CN¥22.44 Million
≈ $3.28 Million
0.007x +157.34%
2024-12-31 CN¥3.98 Billion
≈ $582.75 Million
CN¥-50.12 Million
≈ $-7.33 Million
-0.013x +86.79%
2023-12-31 CN¥4.98 Billion
≈ $729.35 Million
CN¥-474.89 Million
≈ $-69.49 Million
-0.095x -125.89%
2022-12-31 CN¥5.85 Billion
≈ $856.33 Million
CN¥2.15 Billion
≈ $315.14 Million
0.368x +74.98%
2021-12-31 CN¥5.13 Billion
≈ $750.87 Million
CN¥1.08 Billion
≈ $157.92 Million
0.210x -40.02%
2020-12-31 CN¥3.90 Billion
≈ $570.55 Million
CN¥1.37 Billion
≈ $200.06 Million
0.351x +279.08%
2019-12-31 CN¥2.69 Billion
≈ $393.70 Million
CN¥248.87 Million
≈ $36.42 Million
0.093x +77.28%
2018-12-31 CN¥2.43 Billion
≈ $355.59 Million
CN¥126.79 Million
≈ $18.55 Million
0.052x -17.01%
2017-12-31 CN¥2.08 Billion
≈ $304.24 Million
CN¥130.71 Million
≈ $19.13 Million
0.063x -57.51%
2016-12-31 CN¥1.90 Billion
≈ $278.14 Million
CN¥281.25 Million
≈ $41.16 Million
0.148x +13.84%
2015-12-31 CN¥1.73 Billion
≈ $252.51 Million
CN¥224.30 Million
≈ $32.82 Million
0.130x -34.00%
2014-12-31 CN¥1.27 Billion
≈ $185.50 Million
CN¥249.64 Million
≈ $36.53 Million
0.197x -4.92%
2013-12-31 CN¥1.21 Billion
≈ $176.79 Million
CN¥250.22 Million
≈ $36.62 Million
0.207x +5.27%
2012-12-31 CN¥1.09 Billion
≈ $158.98 Million
CN¥213.74 Million
≈ $31.28 Million
0.197x -8.18%
2011-12-31 CN¥1.03 Billion
≈ $150.12 Million
CN¥219.80 Million
≈ $32.16 Million
0.214x -17.48%
2010-12-31 CN¥931.34 Million
≈ $136.28 Million
CN¥241.83 Million
≈ $35.39 Million
0.260x -5.36%
2009-12-31 CN¥792.82 Million
≈ $116.01 Million
CN¥217.51 Million
≈ $31.83 Million
0.274x +28.29%
2008-12-31 CN¥643.75 Million
≈ $94.20 Million
CN¥137.66 Million
≈ $20.14 Million
0.214x -7.88%
2007-12-31 CN¥486.48 Million
≈ $71.19 Million
CN¥112.93 Million
≈ $16.53 Million
0.232x +5.95%
2006-12-31 CN¥398.02 Million
≈ $58.24 Million
CN¥87.21 Million
≈ $12.76 Million
0.219x +12.77%
2005-12-31 CN¥380.71 Million
≈ $55.71 Million
CN¥73.97 Million
≈ $10.82 Million
0.194x +52.22%
2004-12-31 CN¥381.82 Million
≈ $55.87 Million
CN¥48.74 Million
≈ $7.13 Million
0.128x -71.25%
2003-12-31 CN¥158.92 Million
≈ $23.26 Million
CN¥70.57 Million
≈ $10.33 Million
0.444x +56.53%
2002-12-31 CN¥146.21 Million
≈ $21.39 Million
CN¥41.48 Million
≈ $6.07 Million
0.284x --

About Shanghai Kehua Bio-Engineering Co Ltd

SHE:002022 China Medical Devices
Market Cap
$358.26 Million
CN¥2.45 Billion CNY
Market Cap Rank
#13939 Global
#4148 in China
Share Price
CN¥4.76
Change (1 day)
-3.05%
52-Week Range
CN¥4.76 - CN¥8.06
All Time High
CN¥29.42
About

Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more